Rossari Biotech Limited (ROSSARI) - Cash Flow Conversion Efficiency

Latest as of September 2023: 0.031x

Based on the latest financial reports, Rossari Biotech Limited (ROSSARI) has a cash flow conversion efficiency ratio of 0.031x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs302.28 Million ≈ $3.27 Million USD) by net assets (Rs9.78 Billion ≈ $105.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ROSSARI cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Rossari Biotech Limited - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Rossari Biotech Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Rossari Biotech Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Rossari Biotech Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Materialise NV NASDAQ:MTLS	0.027x
Rotshtein TA:ROTS	-0.082x
Tus Pharmaceutical Group Co Ltd SHE:000590	0.004x
Ld Intelligent Technology Co Ltd SHE:300883	0.008x
Shenzhen Ecobeauty Co Ltd SHE:000010	0.086x
Zhejiang Dayang Biotech Group Co SHE:003017	0.001x
Alandsbanken Abp A HE:ALBAV	0.054x
Formosan Union Chemical Corp TW:1709	0.023x

Annual Cash Flow Conversion Efficiency for Rossari Biotech Limited (2017–2025)

The table below shows the annual cash flow conversion efficiency of Rossari Biotech Limited from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see Rossari Biotech Limited stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs11.85 Billion ≈ $128.20 Million	Rs1.37 Billion ≈ $14.86 Million	0.116x	+180.84%
2024-03-31	Rs10.48 Billion ≈ $113.31 Million	Rs432.55 Million ≈ $4.68 Million	0.041x	-75.21%
2023-03-31	Rs9.15 Billion ≈ $98.97 Million	Rs1.52 Billion ≈ $16.48 Million	0.167x	+356.69%
2022-03-31	Rs8.05 Billion ≈ $87.08 Million	Rs293.58 Million ≈ $3.17 Million	0.036x	-68.80%
2021-03-31	Rs4.09 Billion ≈ $44.21 Million	Rs477.67 Million ≈ $5.17 Million	0.117x	-38.90%
2020-03-31	Rs2.87 Billion ≈ $31.00 Million	Rs548.28 Million ≈ $5.93 Million	0.191x	-66.73%
2019-03-31	Rs1.24 Billion ≈ $13.39 Million	Rs711.77 Million ≈ $7.70 Million	0.575x	+95.79%
2018-03-31	Rs870.80 Million ≈ $9.42 Million	Rs255.69 Million ≈ $2.77 Million	0.294x	+287.66%
2017-03-31	Rs619.85 Million ≈ $6.70 Million	Rs46.95 Million ≈ $507.75K	0.076x	--

About Rossari Biotech Limited

NSE:ROSSARI India Specialty Chemicals

Market Cap

$319.65 Million

Rs29.56 Billion INR

Market Cap Rank

#14609 Global

#728 in India

Share Price

Rs533.70

Change (1 day)

+4.15%

52-Week Range

Rs378.60 - Rs743.30

All Time High

Rs1568.62